Atorvastatin TAD 40mg film-coated Tablets Malta - inglise - Malta Medicines Authority

atorvastatin tad 40mg film-coated tablets

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - atorvastatin - film-coated tablet - atorvastatin 40 mg - lipid modifying agents

Lipitor 10mg film-coated tablets Malta - inglise - Malta Medicines Authority

lipitor 10mg film-coated tablets

pfizer hellas s.a. - atorvastatin - film-coated tablet - atorvastatin 10 milligram(s) - lipid modifying agents

Lipitor Tablets Chewable 5mg Malta - inglise - Malta Medicines Authority

lipitor tablets chewable 5mg

pfizer hellas s.a. - atorvastatin calcium - chewable tablet - atorvastatin calcium 5 milligram(s) - lipid modifying agents

Lipitor Tablets Chewable 10mg Malta - inglise - Malta Medicines Authority

lipitor tablets chewable 10mg

pfizer hellas s.a. - atorvastatin calcium - chewable tablet - atorvastatin calcium 10 milligram(s) - lipid modifying agents

Lipitor Tablets Chewable 20mg Malta - inglise - Malta Medicines Authority

lipitor tablets chewable 20mg

pfizer hellas s.a. - atorvastatin calcium - chewable tablet - atorvastatin calcium 20 milligram(s) - lipid modifying agents

Lipitor Tablets Chewable 40mg Malta - inglise - Malta Medicines Authority

lipitor tablets chewable 40mg

pfizer hellas s.a. - atorvastatin calcium - chewable tablet - atorvastatin calcium 40 milligram(s) - lipid modifying agents

Atorvastatin Crystalline 10mg Tablets Suurbritannia - inglise - myHealthbox

atorvastatin crystalline 10mg tablets

zentiva - atorvastatin - film-coated tablets - 10mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

Atorvastatin Crystalline 20mg Tablets Suurbritannia - inglise - myHealthbox

atorvastatin crystalline 20mg tablets

zentiva - atorvastatin - film-coated tablets - 20mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

Atorvastatin Crystalline 80mg Tablets Suurbritannia - inglise - myHealthbox

atorvastatin crystalline 80mg tablets

zentiva - atorvastatin - film-coated tablets - 80mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

 Atorvastatin Crystalline 40mg Tablets Suurbritannia - inglise - myHealthbox

atorvastatin crystalline 40mg tablets

zentiva - atorvastatin - film-coated tablets - 40mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.